Download full-text PDF

Source

Publication Analysis

Top Keywords

oral cephalosporin
4
cephalosporin therapy
4
therapy acute
4
acute bacterial
4
bacterial bronchopneumopathy]
4
oral
1
therapy
1
acute
1
bacterial
1
bronchopneumopathy]
1

Similar Publications

Objective: The aim of this study was to determine if oral beta-lactam therapy is non-inferior to alternative therapy at discharge following inpatient treatment with an IV cephalosporin for acute pyelonephritis.

Design: Institutional Review Board (IRB)-approved, multicenter, retrospective, non-inferiority cohort (15% non-inferiority margin).

Setting: Six hospitals within two healthcare systems.

View Article and Find Full Text PDF

Background: Cancer is a significant global health issue due to its high incidence and mortality rates. In recent years, the relationship between the human microbiota and cancer has garnered attention across various medical fields. This includes research into the microbial communities that influence cancer development, tumor-associated microorganisms, and the interactions between the microbiome and tumor, collectively referred to as the oncobiome.

View Article and Find Full Text PDF

Intermittent High-Degree AV Block, Rash, and Facial Droop with Negative Lyme PCR.

J Emerg Med

January 2025

Department of Emergency Medicine, University of Kentucky, Lexington, Kentucky.

Background: Lyme disease is the most common tick-borne illness in the United States, and cases of Lyme disease have nearly doubled since the early 2000s. Symptoms and presentation vary based on severity of illness, with more serious complications of disease consisting of neurologic and cardiac dysfunction. Testing is often unreliable, which can lead to delayed diagnosis and management.

View Article and Find Full Text PDF
Article Synopsis
  • The effectiveness of ceftriaxone in determining susceptibility to newer oral cephalosporins is uncertain.
  • In a study of 409 bloodstream isolates of Enterobacterales, ceftriaxone susceptibility correlated with high rates of susceptibility to cefuroxime (89%), cefdinir (86%), cefpodoxime (90%), and cefixime (94%).
  • When focusing only on isolates that were susceptible to ceftriaxone, the susceptibility rates for the four oral cephalosporins increased to between 92% and 99%.
View Article and Find Full Text PDF

Preliminary report: Protective effects of probiotics on cefovecin-induced gut dysbiosis in dogs.

Can J Vet Res

January 2025

Laboratory of Veterinary Dermatology (Han, Hwang) and Research Institute for Veterinary Science (Han, Mun, Hwang), College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea; ORIGIN Veterinary Dermatology Clinic, Busan, Republic of Korea (Kang); Department of Companion Animal Health Care, College of Medical Health, Kyungbok University, Namyangju, Republic of Korea (Kim S-J); Department of Large Animal Internal Medicine, College of Veterinary Medicine, Kangwon National University, Chuncheon, Republic of Korea (Kim Y-H).

The objective of this study was to evaluate whether supplementation with probiotics over a 2-week period stabilizes the gut microbiota in dogs following prolonged cefovecin treatment. A significant number of clinical veterinarians prescribe oral probiotics to dogs in conjunction with systemic antibiotics with the intention of protecting against gut dysbiosis. The effects of antibiotics and probiotics in dogs have not been extensively studied, however, and the optimal treatment for gut dysbiosis remains uncertain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!